![]() All finished products are tested for Cronobacter sakazakii, Salmonella Newport and other pathogens and they must test negative before any product is released. Abbott conducts extensive quality checks on each completed batch of infant formula, including microbiological analysis prior to release. ![]() Importantly, no distributed product has tested positive for the presence of either of these bacteria, and we continue to test. We found no evidence of Salmonella Newport. During testing in our Sturgis, Mich., facility, we found evidence of Cronobacter sakazakii in the plant in non-product contact areas. ![]() The recall does not include any metabolic deficiency nutrition formulas.Ībbott is voluntarily recalling these products after four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility.Īdditionally, as part of Abbott's quality processes, we conduct routine testing for Cronobacter sakazakii and other pathogens in our manufacturing facilities. ![]() 17, 2022 / PRNewswire/ - Abbott (NYSE: ABT) is initiating a proactive, voluntary recall of powder formulas, including Similac, Alimentum and EleCare manufactured in Sturgis, Mich., one of the company's manufacturing facilities. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |